This article focuses on EXE's merger and how it became the largest U.S. natural gas producer. The company has strong financial health but trades at a discounted valuation as its 3.32x EV/EBITDA is well below the industry benchmark of about 5.0x. Investment thesis centers on the company's cyclical nature and potential for both risk and opportunity.

